Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2025-12-25 @ 11:17 PM
NCT ID: NCT02550093
Description: Assessments completed 24 hours after participants who completed study interventions.
Frequency Threshold: 0
Time Frame: 24hrs after intervention.
Study: NCT02550093
Study Brief: The Effect of Intranasal Oxytocin on Pain Sensitivity and Threshold
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Oxytocin Subjects received nasal spray(s) into each nostril of 4 Units up to 32 units of Oxytocin prior to Thermal Evaluation System Testing. 0 None 0 20 0 20 View
Normal Saline Subjects received nasal spray(s) into each nostril of Normal Saline prior to Thermal Evaluation System Testing. 0 None 0 20 0 20 View
Serious Events(If Any):
Other Events(If Any):